Obesity is a global health crisis with profound clinical and societal consequences, contributing to increased risks of ...

During a live event, Saby George, MD, and participants discussed tolerability concerns in patients with recurrent renal cell ...

Finerenone treatment vs placebo was associated with a reduced risk for new-onset diabetes by 24% among patients with HFmrEF or HFpEF.

Cabozantinib is a vascular endothelial growth factor receptor tyrosine kinase inhibitor, a drug used as a therapy for several ...

Disclosures The study was funded by Cancer Research UK, GE Healthcare, and Bayer. The study authors had ... the BRAID randomised controlled trial" Lancet 2025; DOI: 10.1016/S0140-6736(25)00582-3.

CC acknowledges grants or contracts from Echosens, Gilead, and Novo Nordisk, consulting fees from Gilead, Novo Nordisk, AstraZeneca, Elli Lilly, E-scopics, MSD, Bayer, and Echosens, payment or ...

CHMP recommends third indication for darolutamide for patients with advanced prostate cancer CHMP adopts positive opinion for the marketing authorisation of darolutamide in combination with androgen ...

Bayer Pharmaceuticals is committed to a “tiered pricing approach” to bring its innovative products into India, said Shweta Rai, Managing Director (India) and Country Division Head (South Asia ...

Initiating intensive blood pressure lowering soon after ICH is linked to better outcomes compared to currently recommended ...

On Thursday, Goldman Sachs analyst James Quigley upgraded Bayer Aktiengesellschaft (OTC:BAYRY) to Buy from Neutral, while setting a price target of EUR 33. Quigley indicated that the stock's risk ...

May 23 (Reuters) - German drugmaker Bayer (BAYGn.DE), opens new tab on Friday won an endorsement by the European Medicines Agency to extend the intervals between shots of its anti-blindness ...